DE2164565A1 - Verfahren zur gewinnung von krebshemmenden stoffen - Google Patents

Verfahren zur gewinnung von krebshemmenden stoffen

Info

Publication number
DE2164565A1
DE2164565A1 DE2164565A DE2164565A DE2164565A1 DE 2164565 A1 DE2164565 A1 DE 2164565A1 DE 2164565 A DE2164565 A DE 2164565A DE 2164565 A DE2164565 A DE 2164565A DE 2164565 A1 DE2164565 A1 DE 2164565A1
Authority
DE
Germany
Prior art keywords
cancer cells
cancer
animal
antibodies
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE2164565A
Other languages
German (de)
English (en)
Inventor
Walter Prof Dr Hartenbach
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to DE2164565A priority Critical patent/DE2164565A1/de
Priority to CH1881772A priority patent/CH574246A5/xx
Priority to FR7245990A priority patent/FR2164900A1/fr
Priority to JP47129434A priority patent/JPS4868733A/ja
Publication of DE2164565A1 publication Critical patent/DE2164565A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE2164565A 1971-12-24 1971-12-24 Verfahren zur gewinnung von krebshemmenden stoffen Pending DE2164565A1 (de)

Priority Applications (4)

Application Number Priority Date Filing Date Title
DE2164565A DE2164565A1 (de) 1971-12-24 1971-12-24 Verfahren zur gewinnung von krebshemmenden stoffen
CH1881772A CH574246A5 (enExample) 1971-12-24 1972-12-22
FR7245990A FR2164900A1 (en) 1971-12-24 1972-12-22 Carcinostatic immunogammaglobulin prodn - from blood of animals injected with human cancer-cells
JP47129434A JPS4868733A (enExample) 1971-12-24 1972-12-25

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2164565A DE2164565A1 (de) 1971-12-24 1971-12-24 Verfahren zur gewinnung von krebshemmenden stoffen

Publications (1)

Publication Number Publication Date
DE2164565A1 true DE2164565A1 (de) 1973-06-28

Family

ID=5829213

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2164565A Pending DE2164565A1 (de) 1971-12-24 1971-12-24 Verfahren zur gewinnung von krebshemmenden stoffen

Country Status (4)

Country Link
JP (1) JPS4868733A (enExample)
CH (1) CH574246A5 (enExample)
DE (1) DE2164565A1 (enExample)
FR (1) FR2164900A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO793412L (no) * 1978-10-25 1980-05-06 Benzon As Alfred Fremgangsmaate for fremstilling av overfoeringsfaktor mot patogene antigener

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE691940C (de) * 1932-12-10 1940-06-08 Maria Katharina Remmets Geb Re Verfahren zur Herstellung eines Krebsserums

Also Published As

Publication number Publication date
JPS4868733A (enExample) 1973-09-19
FR2164900A1 (en) 1973-08-03
CH574246A5 (enExample) 1976-04-15
FR2164900B1 (enExample) 1976-07-02

Similar Documents

Publication Publication Date Title
DE1598832A1 (de) Auf der Beobachtung eines Agglutinationsvorganges beruhendes Verfahren zum Nachweis von Choriongonadotropin in Koerperfluessigkeiten
DE2644766A1 (de) Arzneimittel
DE1720120A1 (de) Injizierbare Zusatzmittel,Verfahren ihrer Herstellung und Verwendung und neue medizinische Zusammensetzungen,die dieses Zusatzmittel enthalten
DE2138453B2 (de) Verfahren zum Gewinnen eines arzneilichen Extraktes gegen hohen Blutdruck aus den Hyphen des Pilzes Lentinus edodes
DE69220939T2 (de) Gegengift immunsera
DE2352662A1 (de) Verfahren zur herstellung eines uebertragungsfaktors
DE2164565A1 (de) Verfahren zur gewinnung von krebshemmenden stoffen
DE3341367A1 (de) Melanomdiagnosemittel mit gehalt an monoklonem spezifischen antikoerper
CH392780A (de) Verfahren zur Herstellung von intravenös anwendbaren Antikörperpräparaten humanen Ursprungs
DE2620287A1 (de) Verfahren zur wachstumsfoerderung von tieren
EP0923607A1 (de) Verfahren zur herstellung polyklonaler und monoklonaler antikörper
DE2513848A1 (de) Verfahren zur gewinnung ununterbrochener staemme von tumorzellen in vitro
DE1492243C3 (de) Injizierbare Impfstoffe
DE2420415A1 (de) Eine mitogenische blutfraktion und verfahren zur herstellung derselben
DE2015804A1 (de) Verfahren zur Herstellung eines antigenen oder allergenen Extraktes
DE1617538C3 (de) Verfahren zur Herstellung von Tetanus-Antitoxin
DE2728802C2 (de) Verfahren zum Herstellen eines antischistosomen immunologischen Mittels
DE2806910A1 (de) Mittel zur desensibilisierung von flohstichen
Hülsebusch Immunoglobulin G status of camels during 6 months post natum
Wiidik et al. Untersuchungen über die antigene Struktur von Vibrio fetus vom Rind. Das Kapsel‐oder K‐Antigen von Vibrio fetus
EP0183253A2 (de) Arzneimittel enthaltend einen aus den Peyer'schen Plaques hergestellten Organextrakt zur Behandlung bei Diabetes Mellitus und Pankreatitis
DE870322C (de) Verfahren zur Herstellung von immunisierenden und sensibilisierenden Fraktionen des Serums
DE2032988A1 (en) Ovular and seminal cell extracts - having a haploid chromosome set for therapeutic and diagnostic use
DE238162C (enExample)
DE2951412A1 (de) Verfahren zur herstellung immunologisch reaktiver praeparate

Legal Events

Date Code Title Description
OHA Expiration of time for request for examination